Low birthweight · healthy pregnant women receiving calcium supplementation vs placebo or no treatment
Calcium supplementation showed no clear difference in low birthweight (< 2500 g) compared with placebo or no treatment (maternal outcomes) (moderate certainty).
1 finding from 1 review
Persons with hypercalcaemia ‐ Vitamin D (D2, D3 or 25(OH)D) plus calcium (1 year estimate) · post‐menopausal women and older people at risk of osteoporotic fractures
Vitamin D [D2, D3 or 25(OH)D] plus calcium showed no clear difference in persons with hypercalcaemia ‐ Vitamin D (D2, D3 or 25(OH)D) plus… compared with control or placebo (low certainty).
1 finding from 1 review
Persons with renal disease (calculi or insufficiency) ‐ Vitamin D (D2, D3 or 25(OH)D) plus calcium (1 year estimate) · post‐menopausal women and older people at risk of osteoporotic fractures
Vitamin D [D2, D3 or 25(OH)D] plus calcium leads to higher persons with renal disease (calculi or insufficiency) ‐ Vitamin D… compared with control or placebo (high certainty).
1 finding from 1 review
Deaths ‐ Vitamin D (D2, D3, 25(OH)D) plus calcium (1 year estimate) · post‐menopausal women and older people at risk of osteoporotic fractures
Vitamin D [D2, D3 or 25(OH)D] plus calcium showed no clear difference in deaths ‐ Vitamin D (D2, D3, 25(OH)D) plus calcium (1 year estimate) compared with control or placebo (high certainty).
1 finding from 1 review
Frequency of leg cramps after treatment: never · treating leg cramps in pregnancy
It is very uncertain whether oral calcium changes frequency of leg cramps after treatment: never compared with no treatment (very low certainty).
2 findings from 1 review
Frequency of leg cramps after treatment: never · treating leg cramps in pregnancy
It is very uncertain whether oral calcium changes frequency of leg cramps after treatment: never compared with oral vitamin C (very low certainty).
1 finding from 1 review
Serum phosphorus · people with CKD‐MBD
1 finding from 1 review
Alkaline phosphatase · people with CKD‐MBD
1 finding from 1 review
All‐cause mortality · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular events · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fracture · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death or dependency at end of · people with acute ischemic stroke
Calcium antagonists showed no clear difference in death or dependency at end of compared with placebo (moderate certainty).
1 finding from 1 review
Death at the end of treatment · people with acute ischemic stroke
Calcium antagonists showed no clear difference in death at the end of treatment compared with placebo (moderate certainty).
1 finding from 1 review
Death at the end of · people with acute ischemic stroke
Calcium antagonists showed no clear difference in death at the end of compared with placebo (moderate certainty).
1 finding from 1 review
Recurrence of stroke at the end of · people with acute ischemic stroke
Calcium antagonists showed no clear difference in recurrence of stroke at the end of compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events during treatment period · people with acute ischemic stroke
Calcium antagonists showed no clear difference in adverse events during treatment period compared with placebo (moderate certainty).
1 finding from 1 review
Hypotension · people with acute ischemic stroke
Calcium antagonists showed no clear difference in hypotension during treatment period compared with placebo (moderate certainty).
1 finding from 1 review
Systolic blood pressure · people with acute ischemic stroke
Calcium antagonists showed no clear difference in mean systolic blood pressure during or at end of treatment compared with placebo (low certainty).
1 finding from 1 review
Overall success (composite of clinical and radiographic success) · Vital permanent teeth (mature or immature) with deep or extremely deep caries and asymptomatic pulp or reversible pulpitis, undergoing…
At 36-month follow-up, HCSC show higher odds of clinical and radiographic success than CaOH (OR 2.34, 95% CI 1.43 to 3.84; ungraded subgroup).
3 findings from 1 review
OR 2.34 [1.43, 3.84]
2 studies · 379 participants
GRADE not reported
OR 4.44 [1.63, 12.07]
3 studies · 174 participants
GRADE not reported
OR 2.68 [1.7, 4.22]
5 studies · 552 participants
Moderate
Total hip BMD · premenopausal women (ages 18–36 years)
1 finding from 1 review